Class I–restricted presentation is usually associated with cytoplasmic degradation of cellular proteins and is often considered inaccessible to exogenous antigens. Nonetheless, certain exogenous elements can gain entry into this so-called endogenous pathway by a mechanism termed cross-presentation. This is known to be effective for class I–restricted cytotoxic T lymphocyte (CTL) cross-priming directed against a variety of exogenous tumor, viral, and minor transplantation antigens. The related effect of cross-tolerance can also effectively eliminate responses to selected self components. In both cases, this presentation appears to require the active involvement of a bone marrow–derived antigen presenting cell (APC). Here, we show that CTL induction by cross-priming with cell-associated ovalbumin requires the active involvement of CD4+ helper T cells. Importantly, this CD4+ population is only effective when both the helper and CTL determinants are recognized on the same APC. Moreover, we would argue that the cognitive nature of this event suggests that the CD4+ T cell actively modifies the APC, converting it into an effective stimulator for the successful priming of the CTL precursor.
Skip Nav Destination
Article navigation
7 July 1997
Article Contents
Article|
July 07 1997
Induction of a CD8+ Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4+ T Cell Help
Sally R.M. Bennett,
Sally R.M. Bennett
From the *Thymus Biology Unit, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, QLD 4029, Australia; and §The Monash Medical School, Alfred Hospital, Prahran, Victoria 3181, Australia
Search for other works by this author on:
Francis R. Carbone,
Francis R. Carbone
From the *Thymus Biology Unit, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, QLD 4029, Australia; and §The Monash Medical School, Alfred Hospital, Prahran, Victoria 3181, Australia
Search for other works by this author on:
Freda Karamalis,
Freda Karamalis
From the *Thymus Biology Unit, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, QLD 4029, Australia; and §The Monash Medical School, Alfred Hospital, Prahran, Victoria 3181, Australia
Search for other works by this author on:
Jacques F.A.P. Miller,
Jacques F.A.P. Miller
From the *Thymus Biology Unit, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, QLD 4029, Australia; and §The Monash Medical School, Alfred Hospital, Prahran, Victoria 3181, Australia
Search for other works by this author on:
William R. Heath
William R. Heath
From the *Thymus Biology Unit, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, QLD 4029, Australia; and §The Monash Medical School, Alfred Hospital, Prahran, Victoria 3181, Australia
Search for other works by this author on:
Sally R.M. Bennett
,
Francis R. Carbone
,
Freda Karamalis
,
Jacques F.A.P. Miller
,
William R. Heath
From the *Thymus Biology Unit, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, QLD 4029, Australia; and §The Monash Medical School, Alfred Hospital, Prahran, Victoria 3181, Australia
Address correspondence to William R. Heath, Thymus Biology Unit, The Walter and Eliza Hall Institute, Post Office The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia. Phone: 61-3-93452555, FAX: 61-3-9347-0852, E-Mail: [email protected]
1Abbreviations used in this paper: cGy, centiGrey; K, H-2K; HEM, Hepes Eagle's medium.
Received:
March 13 1997
Revision Received:
April 17 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 186 (1): 65–70.
Article history
Received:
March 13 1997
Revision Received:
April 17 1997
Citation
Sally R.M. Bennett, Francis R. Carbone, Freda Karamalis, Jacques F.A.P. Miller, William R. Heath; Induction of a CD8+ Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4+ T Cell Help. J Exp Med 7 July 1997; 186 (1): 65–70. doi: https://doi.org/10.1084/jem.186.1.65
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement